Abbott Laboratories (ABT) Cash & Equivalents (2009 - 2026)
Abbott Laboratories (ABT) posted Cash & Equivalents of $5.1 billion for Q2 2026, down 24.97% sequentially from $6.8 billion in Q1 2026, and down 26.57% YoY from $7.0 billion in Q2 2025.
Abbott Laboratories (ABT) Cash & Equivalents (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Cash & Equivalents for 18 years, with the latest figure at $5.1 billion in Q2 2026.
- Quarterly Cash & Equivalents fell 26.57% year-over-year to $5.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.1 billion (down 26.57% YoY) and the FY2025 annual result came in at $8.5 billion, up 11.9% from the prior year.
- Cash & Equivalents fell to $5.1 billion in Q2 2026 per ABT's latest filing, from $6.8 billion in the prior quarter.
- Over five years, Cash & Equivalents peaked at $9.9 billion in Q4 2022 and troughed at $5.1 billion in Q2 2026.
- A 5-year average of $7.6 billion and a median of $7.5 billion in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents advanced 19.36% in 2023, then tumbled 31.4% in 2024.
- Over 5 years, Cash & Equivalents stood at $9.9 billion in 2022, then tumbled by 30.22% to $6.9 billion in 2023, then increased by 10.44% to $7.6 billion in 2024, then advanced by 11.9% to $8.5 billion in 2025, then plunged by 40.11% to $5.1 billion in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $5.1 billion, $6.8 billion, and $8.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.29 Bn | 123.81 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.14 Bn | 72.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.68 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.19 Bn | 18.78 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.10 Bn |
| Mar 31, 2026 | 6.80 Bn |
| Dec 31, 2025 | 8.52 Bn |
| Sep 30, 2025 | 7.51 Bn |
| Jun 30, 2025 | 6.95 Bn |
| Mar 31, 2025 | 6.53 Bn |
| Dec 31, 2024 | 7.62 Bn |
| Sep 30, 2024 | 7.56 Bn |
| Jun 30, 2024 | 6.99 Bn |
| Mar 31, 2024 | 6.28 Bn |
| Dec 31, 2023 | 6.90 Bn |
| Sep 30, 2023 | 6.71 Bn |
| Jun 30, 2023 | 7.84 Bn |
| Mar 31, 2023 | 9.16 Bn |
| Dec 31, 2022 | 9.88 Bn |
| Sep 30, 2022 | 9.59 Bn |
| Jun 30, 2022 | 8.94 Bn |
| Mar 31, 2022 | 7.68 Bn |
| Dec 31, 2021 | 9.80 Bn |
| Sep 30, 2021 | 9.30 Bn |